JPRN-UMIN000037192
Completed
未知
Additive effect of inhaled corticosteroid (ICS) on patients with COPD receiving long acting muscarinic antagonist (LAMA)/long acting beta2 agonist (LABA) single center, real world study - Additive effect of inhaled corticosteroid (ICS) on patients with COPD receiving long acting muscarinic antagonist (LAMA)/long acting beta2 agonist (LABA) single center, real world study
Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School0 sites37 target enrollmentJune 27, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School
- Enrollment
- 37
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
not analysed, yet.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Excluded from the study were those with a documented history of asthma or a bronchodilator response (BDR) to 400g salbutamol shown as a FEV1 change of 200ml or more than 200 mL and those confirmed to have received LAMA, LABA or ICS other than the study drug or their combination.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
The effect of inhaled corticosteroids (ICS) on airway smooth muscle in asthma - ICS and ASM in asthmaAsthma is a disease characterised by reversible airways obstruction, bronchial hyper-responsiveness (BHR), and chronic inflammation of the bronchial mucosal lining. Structural changes in the airway wall, collectively known as airway wall remodelling, include, subbasement membrane thickening, smooth muscle hyperplasia/hypertrophy, and collagen deposition. These changes may be responsible for an increased decline in lung function, irreversible airflow obstruction and BHR seen in chronic asthma.MedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2007-006664-29-GBImperial College12
Completed
Phase 3
Does inhaled corticosteroid predispose asthmatic patients to diabetes?Chronic lower respiratory diseases.AsthmaIRCT201605247411N2Ahvaz Jundishapur University of Medical Science28
Recruiting
Phase 2
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPDChronic Obstructive Pulmonary DiseaseNCT05607719University of Miami30
Completed
Phase 2
Evaluation of Inhaled Treatment in SinusitisSinusitisNCT01907204Cliniques universitaires Saint-Luc- Université Catholique de Louvain50
Completed
Not Applicable
Prevention of thunderstorm asthmaThunderstorm asthma.AsthmaIRCT2016102520828N2Ahvaz Jundishapur University of Medical Sciences54